France Bleu will cancel the publication, on Monday, December 30, of an article that analyzed the popularity of a link between Charcot’s disease and the Pfizer/Bionntech vaccine against COVID-19. This article was published based on fragmentary data, which leads to an interpretation error. France Bleu has chosen to after the article not to disseminate false data on this delicate topic. It is not at all about a matter of censorship, as commented on social networks, but a rectification.
Contrary to what the France Bleu Pays d’Auvergne article indicates, the French government has never demonstrated a link between vaccination against Covid-19 and amyotrophic lateral sclerosis (ALS, Charcot’s disease). To date, the role of the vaccine in the onset of the disease of the patient has been recognized.
L’article mentionnait une reconnaissance par un organisme de pharmacovigilance. La pharmacovigilance est la surveillance, l’évaluation, la prévention et la gestion du risque d’effet indésirable avant et après la commercialisation des médicaments et des vaccins. En France, pour être mis sur le marché, un médicament ou un vaccin doit passer un essai clinique lors duquel les autorités sanitaires regardent si le produit testé sur des milliers de personnes provoque des effets secondaires indésirables ou graves. En décembre 2020, le vaccin de Pfizer/BioNTech a passé toutes les étapes avec succès et son utilisation a été autorisée par l’Agence européenne des médicaments, puis par la Haute autorité de Santé en France.
After this green light, the surveillance does not stop. There is a phase of the moment with “real-life data”. These are the comments that all other French people who have been vaccinated or who have taken this or that can make. If a patient reports a severe-looking effect, he or his doctor can alert the National Drug Safety Agency (ANSM) or the regional pharmacovigilance medium in his region. Based on these comments, the ANSM conducts statistical and investigative paintings on whether there is a threat to patients and takes action if necessary.
It is the ANSM who makes a decision and not a pharmacovigilance body. And to date, the ANSM has not communicated in any link between Charcot’s disease and the Pfizer vaccine opposed to COVID-19. In addition, billions of doses of this vaccine have injected around the global and has not been taken in the foreign point.
HERE
null
nobody
null
Your radio